What:
Cognilum is a medical device that will be regulated by the FDA prior to launch.
*These statements are based on the results of the double blind placebo controlled Phase I clinical trial and have not yet been evaluated by the FDA.
Meet Julia Krutoy, Speech Therapist who evaluated children in the clinical trial.
Meet a family, whose child received Cognilum treatment.
Meet Dr. Eugenia Steingold, presenting at the Synchrony conference in 2022.
* * * * *
“He is having more frequent and more prolonged eye contact. He said 5 new words this week! He is smiling! He can now concentrate with therapists. Teacher thought he started medications!” *** Mother of a 4-year-old mostly non-verbal autistic son
“He told me “I love you, Mommy”. First time in his life. I cried”. *** Mother of a 4-year-old son diagnosed with ASD
“She is now interested in playing with other children. Incredibly - her teacher decided to transfer her to a more advanced class in school, because she can now speak sentences!” *** Mother of a 5-year-old girl diagnosed with ASD, after 12 treatment sessions
“The Teachers called us and said ‘we don’t know what you’re doing with J, but the shift in his behavior is massive! He’s interacting with us and for the first time asked to use the bathroom - whatever you’re doing, keep it up!” *** Mother of twins both diagnosed with profound ASD
"He now walks on the street holding my hand, without running into oncoming traffic. His teachers said that he is doing work in school - which he has NEVER done before. " *** Mother of a 5 year old boy diagnosed with ASD
“Every day he is getting better and better. He started using hand gestures. He started saying “no” and “hi”. He is interested in other children now.” *** Mother of a 2 year old boy diagnosed with ASD
The device provides treatment through transcranial photobiomodulation (tPBM). tPBM is a treatment that uses gentle LED light to help improve brain function in autistic children.
In summary, tPBM is a non-invasive and painless treatment that uses light to help enhance brain function in autistic children, potentially leading to better overall well-being
We will have a limited supply of the Cognilum device at its anticipated launch in 2024.
Sign up now to guarantee access and support our mission.
Exclusive Waitlist Benefits
$3,750 for 24 sessions
*Upon Cognilum launch, you will be contacted to schedule an evaluation for your child. Please note that price may change.
Autism is a spectrum, where each individual presents with their own symptoms. These may include inability to communicate, self-harm, repetitive behaviors, sensory sensitivity, sleep disorders, anxiety, and attention issues.
The current Standard of Care is behavioral therapy, which is frequently insufficient and requires many hours of 1 to 1 instructions. There are no approved drugs that treat core symptoms of ASD.